Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription 11.02.2019 1 Am J Gastroenterol 6 Anticancer Res 1 BMC Cancer 2 BMC Gastroenterol 1 Cancer Res 1 Clin Res Hepatol Gastroenterol 5 Dig Dis Sci 3 Gastroenterology 1 Gut 8 Hepatology 1 Int J Cancer 3 J Gastroenterol 6 J Hepatol 1 Lancet Gastroenterol Hepatol 6 PLoS One 1 Proc Natl Acad Sci U S A 5 Semin Liver Dis 7 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Gastroenterol

1. FENG J, Qi X, Guo X, Qi X, et al
   Early-Stage Hepatocellular Carcinoma: Radiofrequency Ablation or Resection?
   Am J Gastroenterol. 2019;114:359.
   PubMed     Text format    
   
   

   
   Anticancer Res

2. WATANABE A, Harimoto N, Araki K, Kubo N, et al
   Absolute Neutrophil Count Predicts Postoperative Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma.
   Anticancer Res. 2019;39:941-947.
   PubMed     Text format     Abstract available
   
   
3. WEI CT, Chen LC, Hsiang YP, Hung YJ, et al
   Chrysin-induced ERK1/2 Phosphorylation Enhances the Sensitivity of Human Hepatocellular Carcinoma Cells to Sorafenib.
   Anticancer Res. 2019;39:695-701.
   PubMed     Text format     Abstract available
   
   
4. CHEN JY, Huang WC, Wei CT, Chien PH, et al
   The C-Terminus of Hepatitis B Virus-encoded X Protein Is Required for Lapatinib Sensitivity in Hepatocellular Carcinoma Cells.
   Anticancer Res. 2019;39:721-726.
   PubMed     Text format     Abstract available
   
   
5. HARIMOTO N, Hoshino K, Muranushi R, Hagiwara K, et al
   Impact of Metabolic Parameters of (18)F-Fluorodeoxyglucose Positron-emission Tomography After Hepatic Resection in Patients With Intrahepatic Cholangiocarcinoma.
   Anticancer Res. 2019;39:971-977.
   PubMed     Text format     Abstract available
   
   
6. ARIMA K, Nitta H, Beppu T, Nakagawa S, et al
   Impact of Repeated Hepatectomy on Liver Regeneration in Hepatocellular Carcinoma: A Propensity Score-based Analysis.
   Anticancer Res. 2019;39:965-970.
   PubMed     Text format     Abstract available
   
   
7. YAMAO T, Yamashita YI, Imai K, Umezaki N, et al
   Clinical Significance of Preoperative Hepatocellular Carcinoma With High Lens culinaris Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein.
   Anticancer Res. 2019;39:883-889.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

8. MOGENSEN MB, Rossing M, Ostrup O, Larsen PN, et al
   Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
   BMC Cancer. 2018;18:752.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

9. THANAPIROM K, Treeprasertsuk S, Soonthornworasiri N, Poovorawan K, et al
   The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study.
   BMC Gastroenterol. 2019;19:18.
   PubMed     Text format     Abstract available
   
   
10. ELSEBAEY MA, Tawfik MA, Ezzat S, Selim A, et al
    Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial.
    BMC Gastroenterol. 2019;19:23.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

11. XU F, Li CH, Wong CH, Chen GG, et al
    Genome-wide screening and functional analysis identifies tumor suppressor long non-coding RNAs epigenetically silenced in hepatocellular carcinoma.
    Cancer Res. 2019 Feb 4. pii: 0008-5472.CAN-18-1659.
    PubMed     Text format     Abstract available
    
    

    
    Clin Res Hepatol Gastroenterol

12. LE BAIL B, Chiche L, Balabaud C, Bioulac-Sage P, et al
    Collision of hepatocellular nodules in vascular livers: A medical challenge.
    Clin Res Hepatol Gastroenterol. 2018;42:e83-e85.
    PubMed     Text format    
    
    

    
    Dig Dis Sci

13. LI P, Shan K, Liu Y, Zhang Y, et al
    CircScd1 Promotes Fatty Liver Disease via the Janus Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway.
    Dig Dis Sci. 2019;64:113-122.
    PubMed     Text format     Abstract available
    
    
14. ROSENBLATT R, Mehta A, Snell D, Hissong E, et al
    Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.
    Dig Dis Sci. 2019;64:262-268.
    PubMed     Text format     Abstract available
    
    
15. JIN X, Zimmers TA, Zhang Z, Koniaris LG, et al
    Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy.
    Dig Dis Sci. 2019;64:93-101.
    PubMed     Text format     Abstract available
    
    
16. JIAO Y, Li Y, Lu Z, Liu Y, et al
    High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
    Dig Dis Sci. 2019;64:137-143.
    PubMed     Text format     Abstract available
    
    
17. LEE KC, Hsu WF, Hsieh YC, Chan CC, et al
    Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.
    Dig Dis Sci. 2019;64:102-112.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

18. TAN AT, Yang N, Krishnamoorthy TL, Oei V, et al
    Use of Expression Profiles of HBV DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.
    Gastroenterology. 2019 Jan 31. pii: S0016-5085(19)30348.
    PubMed     Text format     Abstract available
    
    
19. WEI Y, Lao XM, Xiao X, Wang XY, et al
    Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Gastroenterology. 2019 Jan 31. pii: S0016-5085(19)30347.
    PubMed     Text format     Abstract available
    
    
20. MOSSANEN JC, Kohlhepp M, Wehr A, Krenkel O, et al
    CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T and CD4+ T cell-Dependent Control of Senescence.
    Gastroenterology. 2019 Jan 30. pii: S0016-5085(19)30342.
    PubMed     Text format     Abstract available
    
    

    
    Gut

21. MERLEN G, Kahale N, Ursic-Bedoya J, Bidault-Jourdainne V, et al
    TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function.
    Gut. 2019 Feb 5. pii: gutjnl-2018-316975. doi: 10.1136/gutjnl-2018-316975.
    PubMed     Text format     Abstract available
    
    

    
    Hepatology

22. TSANG FH, Law CT, Tang CT, Cheng CL, et al
    Aberrant super-enhancer landscape in human hepatocellular carcinoma.
    Hepatology. 2019 Feb 5. doi: 10.1002/hep.30544.
    PubMed     Text format     Abstract available
    
    
23. DENISOV EV, Perelmuter VM
    A fixed partial epithelial-mesenchymal transition (EMT) triggers carcinogenesis, whereas asymmetrical division of hybrid EMT cells drives cancer progression.
    Hepatology. 2018;68:807-810.
    PubMed     Text format    
    
    
24. LEWIS K, Takebe T
    Tumoroid a la carte: Path for personalization.
    Hepatology. 2018;68:1189-1191.
    PubMed     Text format    
    
    
25. GUO JT, Block TM
    Do hepatitis B surface antigens have any role in viral carcinogenesis?
    Hepatology. 2018 Mar 24. doi: 10.1002/hep.29886.
    PubMed     Text format    
    
    
26. CUMMINGS D, Ferstenberg R
    Recommendations for the Evaluation for Autoimmune Liver Disease in Nonalcoholic Fatty Liver Disease.
    Hepatology. 2018;68:1203.
    PubMed     Text format    
    
    
27. FUJIWARA K, Yasui S, Yokosuka O, Oda S, et al
    A Role of Renal Replacement Therapy for Acute Liver Failure.
    Hepatology. 2018;68:1204.
    PubMed     Text format    
    
    
28. LO GH
    The Use of Steroid for Transcatheter Arterial Chemoembolization: To Relieve Symptoms or to Mask Adverse Events?
    Hepatology. 2018;68:1207.
    PubMed     Text format    
    
    
29. MWANGI SM, Li G, Ye L, Liu Y, et al
    Glial Cell Line Derived Neurotrophic Factor Enhances Autophagic Flux in Mouse and Rat Hepatocytes and Protects Against Palmitate Lipotoxicity.
    Hepatology. 2019 Feb 4. doi: 10.1002/hep.30541.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

30. VAN BEEK AA, Zhou G, Doukas M, Boor PPC, et al
    GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
    Int J Cancer. 2019 Feb 4. doi: 10.1002/ijc.32181.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol

31. HUANG R, Wang J, Xia J, Hao Y, et al
    Potential clinical application of strain elastography in chronic liver diseases.
    J Gastroenterol. 2018;53:795-796.
    PubMed     Text format    
    
    
32. TAJIRI K, Kawai K, Sugiyama T
    Reply to "Letter to Editor submitted by Rui Huang et al. entitled potential clinical application of strain elastography in chronic liver diseases".
    J Gastroenterol. 2018;53:797-798.
    PubMed     Text format    
    
    
33. KANNO M, Kawaguchi K, Honda M, Horii R, et al
    Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis.
    J Gastroenterol. 2019 Feb 1. pii: 10.1007/s00535-019-01551.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

34. SANZ-GARCIA C, Poulsen KL, Bellos D, Wang H, et al
    The non-transcriptional activity of IRF3 modulates hepatic immune cell populations in acute on chronic ethanol administration in mice.
    J Hepatol. 2019 Jan 30. pii: S0168-8278(19)30064.
    PubMed     Text format     Abstract available
    
    
35. SOLA E, Sole C, Gines P
    Reply to: "Midodrine and albumin in decompensated cirrhosis: Down but not out...".
    J Hepatol. 2019 Jan 30. pii: S0168-8278(18)32646.
    PubMed     Text format    
    
    
36. BORST K, Graalmann T, Kalinke U
    Reply to: "Lack of Kupffer cell depletion in diethylnitrosamine-induced hepatic inflammation".
    J Hepatol. 2019 Jan 31. pii: S0168-8278(19)30013.
    PubMed     Text format    
    
    
37. BELDI G, Vuitton D, Lachenmayer A, Heyd B, et al
    Is ex vivo liver resection and autotransplantation a valid alternative treatment for end-stage hepatic alveolar echinococcosis in Europe?
    J Hepatol. 2019 Feb 1. pii: S0168-8278(18)32630.
    PubMed     Text format    
    
    
38. ANDRADE F, Shukla A, Bureau C, Senzolo M, et al
    Reply to: ''Splenic artery aneurysms, portal hypertension and pregnancy".
    J Hepatol. 2019 Feb 4. pii: S0168-8278(19)30017.
    PubMed     Text format    
    
    
39. MORTON A
    Splenic artery aneurysms, portal hypertension and pregnancy.
    J Hepatol. 2019 Feb 4. pii: S0168-8278(18)32638.
    PubMed     Text format    
    
    

    
    Lancet Gastroenterol Hepatol

40. TSOCHATZIS EA, Newsome PN
    Non-alcoholic fatty liver disease and the interface between primary and secondary care.
    Lancet Gastroenterol Hepatol. 2018;3:509-517.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

41. ALISI A, Pampanini V, De Stefanis C, Panera N, et al
    Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD.
    PLoS One. 2018;13:e0201566.
    PubMed     Text format     Abstract available
    
    
42. XU W, Rao Q, An Y, Li M, et al
    Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma.
    PLoS One. 2018;13:e0202763.
    PubMed     Text format     Abstract available
    
    
43. GUMMESSON A, Stromberg U, Schmidt C, Kullberg J, et al
    Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.
    PLoS One. 2018;13:e0202666.
    PubMed     Text format     Abstract available
    
    
44. LAPOINTE-SHAW L, Georgie F, Carlone D, Cerocchi O, et al
    Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study.
    PLoS One. 2018;13:e0201120.
    PubMed     Text format     Abstract available
    
    
45. PELEG N, Sneh Arbib O, Issachar A, Cohen-Naftaly M, et al
    Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease.
    PLoS One. 2018;13:e0202393.
    PubMed     Text format     Abstract available
    
    
46. WANG Y, Ma L, Yuan Z, Zheng J, et al
    Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study.
    PLoS One. 2018;13:e0201525.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

47. BIDKHORI G, Benfeitas R, Klevstig M, Zhang C, et al
    Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes.
    Proc Natl Acad Sci U S A. 2018;115:E11874-E11883.
    PubMed     Text format     Abstract available
    
    

    
    Semin Liver Dis

48. NADEAU BA, Fecher LA, Owens SR, Razumilava N, et al
    Liver Toxicity with Cancer Checkpoint Inhibitor Therapy.
    Semin Liver Dis. 2018;38:366-378.
    PubMed     Text format     Abstract available
    
    
49. REICHERT MC, Lammert F
    ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
    Semin Liver Dis. 2018;38:299-307.
    PubMed     Text format     Abstract available
    
    
50. KEITEL V, Haussinger D
    Role of TGR5 (GPBAR1) in Liver Disease.
    Semin Liver Dis. 2018;38:333-339.
    PubMed     Text format     Abstract available
    
    
51. LIM C, Lahat E, Osseis M, Sotirov D, et al
    Liver Transplantation for Neuroendocrine Tumors: What Have We Learned?
    Semin Liver Dis. 2018;38:351-356.
    PubMed     Text format     Abstract available
    
    
52. HASSAN A, Fontana RJ
    Liver Injury Associated with Sporting Activities.
    Semin Liver Dis. 2018;38:357-365.
    PubMed     Text format     Abstract available
    
    

    
    Transplant Proc

53. CHAE MS, Kim Y, Oh SA, Jeon Y, et al
    Intraoperative Management of a Patient With Impaired Cardiac Function Undergoing Simultaneous ABO-Compatible Liver and ABO-Incompatible Kidney Transplant From 2 Living Donors: A Case Report.
    Transplant Proc. 2018 Sep 7. pii: S0041-1345(18)30985.
    PubMed     Text format     Abstract available
    
    
54. MALI VP, Fukuda A, Shigeta T, Uchida H, et al
    Mild to Moderate Intrapulmonary Shunting in Pediatric Liver Transplantation: Is Screening Necessary?
    Transplant Proc. 2018;50:3496-3500.
    PubMed     Text format     Abstract available
    
    
55. LAMATTINA JC, Akbar H, Sultan S, Hanish SI, et al
    Molecular Adsorbent Recirculating System Support Followed by Liver Transplantation for Multiorgan Failure From Heatstroke.
    Transplant Proc. 2018;50:3516-3520.
    PubMed     Text format     Abstract available
    
    
56. RIVA G, Villanova M, Cima L, Ghimenton C, et al
    Oil Red O Is a Useful Tool to Assess Donor Liver Steatosis on Frozen Sections During Transplantation.
    Transplant Proc. 2018;50:3539-3543.
    PubMed     Text format     Abstract available
    
    
57. ZIMMERMAN MA, Selim M, Kim J, Saeian K, et al
    Impact of a Transplantation Critical Care Model on Short-Term Outcomes Following Liver Transplantation in High Acuity Patients: A Single-Center Experience.
    Transplant Proc. 2018;50:3544-3548.
    PubMed     Text format     Abstract available
    
    
58. CHAE MS, Kim Y, Kim J, Ko YR, et al
    Perioperative Changes in the Psoas Muscle Index in Patients Undergoing ABO-Incompatible Living-Donor Liver Transplantation: A Single-Center Experience.
    Transplant Proc. 2018;50:3656-3660.
    PubMed     Text format     Abstract available
    
    
59. BARTNIK CM, Maheshwari RN, Subramanian RM
    Beating the Odds: A Full-Term Delivery After Liver Transplantation of a Pregnant Hyperthyroid Patient at 19 Weeks' Gestation for Propylthiouracil-Induced Acute Liver Failure.
    Transplant Proc. 2018;50:3995-3999.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: